Now showing items 31-40 of 538
Use of In Vivo and In Vitro Systems to Select Leishmania amazonensis Expressing Green Fluorescent Protein
(Korean Soc Parasitology, Seoul Natl Univ Coll Medi, 2011-12-01)
Various Leishmania species were engineered with green fluorescent protein (GFP) using episomal vectors that encoded an antibiotic resistance gene, such as aminoglycoside geneticin sulphate (G418). Most reports of GFP-Leishmania ...
INTRACELLULAR Leishmania amazonensis KILLING INDUCED BY THE GUANINE NUCLEOSIDE 8-BROMOGUANOSINE
(Instituto de Medicina Tropical, 1998)
Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes
(Elsevier Sci Ireland LtdClareIrlanda, 2005)
In vivo antileishmanial efficacy of miltefosine against Leishmania (Leishmania) amazonensis
(American Society of Parasitologists, 2014-12)
Leishmaniasis, a disease caused by parasites of the Leishmania genus, constitutes a significant health and social problem in many countries and is increasing worldwide. The conventional treatment, meglumine antimoniate ...
Leishmania amazonensis: Partial purification and study of the biochemical properties of the telomerase reverse transcriptase activity from promastigote-stage
(Academic Press Inc. Elsevier B.V., 2014)
Characterization of Leishmania (Leishmania) amazonensis promastigotes resistant to pentamidine
(ACADEMIC PRESS INC ELSEVIER SCIENCE, 2008)
Pentamidine is a second-line agent used in the treatment of leishmaniasis and its mode of action and mechanism of resistance is not well understood. It was previously demonstrated that transfection of promastigotes and ...